HEADER TRANSFERASE/INHIBITOR 03-APR-20 6WF3 TITLE CRYSTAL STRUCTURE OF HUMAN NAA50 IN COMPLEX WITH A COFACTOR DERIVED TITLE 2 INHIBITOR (COMPOUND 1) COMPND MOL_ID: 1; COMPND 2 MOLECULE: N-ALPHA-ACETYLTRANSFERASE 50; COMPND 3 CHAIN: A, B, C, D, E, F; COMPND 4 SYNONYM: HNAA50P,N-ACETYLTRANSFERASE 13,N-ACETYLTRANSFERASE 5,HNAT5, COMPND 5 N-ACETYLTRANSFERASE SAN HOMOLOG,HSAN,N-EPSILON-ACETYLTRANSFERASE 50, COMPND 6 NATE CATALYTIC SUBUNIT, NAA50; COMPND 7 EC: 2.3.1.258,2.3.1.-; COMPND 8 ENGINEERED: YES; COMPND 9 MOL_ID: 2; COMPND 10 MOLECULE: ACE-MET-LEU-GLY-PRO-NH2; COMPND 11 CHAIN: G, H, I, J, K, L; COMPND 12 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: NAA50, MAK3, NAT13, NAT5; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 MOL_ID: 2; SOURCE 9 SYNTHETIC: YES; SOURCE 10 ORGANISM_SCIENTIFIC: SYNTHETIC CONSTRUCT; SOURCE 11 ORGANISM_TAXID: 32630 KEYWDS N-ALPHA-ACETYLTRANSFERASE 50, INHIBITOR COMPLEX, TRANSFERASE, KEYWDS 2 TRANSFERASE-INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR S.E.GREASLEY,J.FENG,Y.-L.DENG,A.E.STEWART REVDAT 3 25-DEC-24 6WF3 1 REMARK LINK REVDAT 2 18-OCT-23 6WF3 1 REMARK REVDAT 1 01-JUL-20 6WF3 0 JRNL AUTH P.P.KUNG,P.BINGHAM,B.J.BURKE,Q.CHEN,X.CHENG,Y.L.DENG,D.DOU, JRNL AUTH 2 J.FENG,G.M.GALLEGO,M.R.GEHRING,S.K.GRANT,S.GREASLEY, JRNL AUTH 3 A.R.HARRIS,K.A.MAEGLEY,J.MEIER,X.MENG,J.L.MONTANO, JRNL AUTH 4 B.A.MORGAN,B.S.NAUGHTON,P.B.PALDE,T.A.PAUL,P.RICHARDSON, JRNL AUTH 5 S.SAKATA,A.SHAGINIAN,W.K.SONNENBURG,C.SUBRAMANYAM, JRNL AUTH 6 S.TIMOFEEVSKI,J.WAN,W.YAN,A.E.STEWART JRNL TITL CHARACTERIZATION OF SPECIFICN-ALPHA-ACETYLTRANSFERASE 50 JRNL TITL 2 (NAA50) INHIBITORS IDENTIFIED USING A DNA ENCODED LIBRARY. JRNL REF ACS MED.CHEM.LETT. V. 11 1175 2020 JRNL REFN ISSN 1948-5875 JRNL PMID 32550998 JRNL DOI 10.1021/ACSMEDCHEMLETT.0C00029 REMARK 2 REMARK 2 RESOLUTION. 2.29 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.11.7 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.29 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 53.71 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 99.4 REMARK 3 NUMBER OF REFLECTIONS : 56653 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.210 REMARK 3 R VALUE (WORKING SET) : 0.208 REMARK 3 FREE R VALUE : 0.243 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : 2880 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.29 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.31 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.82 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : NULL REMARK 3 BIN R VALUE (WORKING + TEST SET) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : 0.2630 REMARK 3 BIN FREE R VALUE : 0.3114 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : 59 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 7506 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 288 REMARK 3 SOLVENT ATOMS : 354 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 56.03 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -22.85020 REMARK 3 B22 (A**2) : 16.40960 REMARK 3 B33 (A**2) : 6.44060 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 5.87570 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.340 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.273 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.208 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.286 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.211 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.902 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.882 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 8334 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 11652 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 2928 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : NULL ; NULL ; NULL REMARK 3 GENERAL PLANES : 1356 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 7956 ; 10.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 1008 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 5722 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.008 REMARK 3 BOND ANGLES (DEGREES) : 1.01 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 3.00 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 17.98 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6WF3 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 15-APR-20. REMARK 100 THE DEPOSITION ID IS D_1000248107. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 12-OCT-15 REMARK 200 TEMPERATURE (KELVIN) : 93 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 17-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : SI(111) REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS3 S 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AUTOPROC REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 56682 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.290 REMARK 200 RESOLUTION RANGE LOW (A) : 53.710 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.4 REMARK 200 DATA REDUNDANCY : 3.400 REMARK 200 R MERGE (I) : 0.05700 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 13.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.29 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.41 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.7 REMARK 200 DATA REDUNDANCY IN SHELL : 3.30 REMARK 200 R MERGE FOR SHELL (I) : 0.52000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: 2OB0 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 55.26 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.75 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: NAA50 APO PROTEIN (14.3 MG/ML) WAS REMARK 280 INCUBATED WITH COMPOUND 1 IN A 1:3 MOLAR RATIO ON ICE FOR 60 REMARK 280 MIN. RESERVOIR SOLUTION CONTAINING 0.2 M AMMONIUM SULFATE AND 30% REMARK 280 (W/V) PEG 3K/4K WAS MIXED 1:1 WITH PROTEIN/LIGAND COMPLEX, REMARK 280 VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 286.15K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 62.08500 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3, 4, 5, 6 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2440 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 8080 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -7.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, G REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2420 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 8160 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -7.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: B, H REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2440 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 8060 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -7.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: C, I REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 4 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2450 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 8150 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -7.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: D, J REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 5 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2460 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 8080 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -7.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: E, K REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 6 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2480 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 8070 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -7.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: F, L REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A -1 REMARK 465 SER A 0 REMARK 465 MET A 1 REMARK 465 LYS A 2 REMARK 465 GLY A 3 REMARK 465 SER A 4 REMARK 465 LYS A 155 REMARK 465 VAL A 156 REMARK 465 PRO A 157 REMARK 465 SER A 158 REMARK 465 GLY A 159 REMARK 465 GLN A 160 REMARK 465 ASN A 161 REMARK 465 ALA A 162 REMARK 465 ASP A 163 REMARK 465 VAL A 164 REMARK 465 GLN A 165 REMARK 465 LYS A 166 REMARK 465 THR A 167 REMARK 465 ASP A 168 REMARK 465 ASN A 169 REMARK 465 GLY B -1 REMARK 465 SER B 0 REMARK 465 MET B 1 REMARK 465 LYS B 2 REMARK 465 GLY B 3 REMARK 465 SER B 4 REMARK 465 LYS B 155 REMARK 465 VAL B 156 REMARK 465 PRO B 157 REMARK 465 SER B 158 REMARK 465 GLY B 159 REMARK 465 GLN B 160 REMARK 465 ASN B 161 REMARK 465 ALA B 162 REMARK 465 ASP B 163 REMARK 465 VAL B 164 REMARK 465 GLN B 165 REMARK 465 LYS B 166 REMARK 465 THR B 167 REMARK 465 ASP B 168 REMARK 465 ASN B 169 REMARK 465 GLY C -1 REMARK 465 SER C 0 REMARK 465 MET C 1 REMARK 465 LYS C 2 REMARK 465 GLY C 3 REMARK 465 SER C 4 REMARK 465 LYS C 155 REMARK 465 VAL C 156 REMARK 465 PRO C 157 REMARK 465 SER C 158 REMARK 465 GLY C 159 REMARK 465 GLN C 160 REMARK 465 ASN C 161 REMARK 465 ALA C 162 REMARK 465 ASP C 163 REMARK 465 VAL C 164 REMARK 465 GLN C 165 REMARK 465 LYS C 166 REMARK 465 THR C 167 REMARK 465 ASP C 168 REMARK 465 ASN C 169 REMARK 465 GLY D -1 REMARK 465 SER D 0 REMARK 465 MET D 1 REMARK 465 LYS D 2 REMARK 465 GLY D 3 REMARK 465 SER D 4 REMARK 465 LYS D 155 REMARK 465 VAL D 156 REMARK 465 PRO D 157 REMARK 465 SER D 158 REMARK 465 GLY D 159 REMARK 465 GLN D 160 REMARK 465 ASN D 161 REMARK 465 ALA D 162 REMARK 465 ASP D 163 REMARK 465 VAL D 164 REMARK 465 GLN D 165 REMARK 465 LYS D 166 REMARK 465 THR D 167 REMARK 465 ASP D 168 REMARK 465 ASN D 169 REMARK 465 GLY E -1 REMARK 465 SER E 0 REMARK 465 MET E 1 REMARK 465 LYS E 2 REMARK 465 GLY E 3 REMARK 465 SER E 4 REMARK 465 LYS E 155 REMARK 465 VAL E 156 REMARK 465 PRO E 157 REMARK 465 SER E 158 REMARK 465 GLY E 159 REMARK 465 GLN E 160 REMARK 465 ASN E 161 REMARK 465 ALA E 162 REMARK 465 ASP E 163 REMARK 465 VAL E 164 REMARK 465 GLN E 165 REMARK 465 LYS E 166 REMARK 465 THR E 167 REMARK 465 ASP E 168 REMARK 465 ASN E 169 REMARK 465 GLY F -1 REMARK 465 SER F 0 REMARK 465 MET F 1 REMARK 465 LYS F 2 REMARK 465 GLY F 3 REMARK 465 SER F 4 REMARK 465 LYS F 155 REMARK 465 VAL F 156 REMARK 465 PRO F 157 REMARK 465 SER F 158 REMARK 465 GLY F 159 REMARK 465 GLN F 160 REMARK 465 ASN F 161 REMARK 465 ALA F 162 REMARK 465 ASP F 163 REMARK 465 VAL F 164 REMARK 465 GLN F 165 REMARK 465 LYS F 166 REMARK 465 THR F 167 REMARK 465 ASP F 168 REMARK 465 ASN F 169 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ARG A 141 CG CD NE CZ NH1 NH2 REMARK 470 ARG B 141 CG CD NE CZ NH1 NH2 REMARK 470 ARG C 141 CG CD NE CZ NH1 NH2 REMARK 470 ARG D 141 CG CD NE CZ NH1 NH2 REMARK 470 ARG E 141 CG CD NE CZ NH1 NH2 REMARK 470 ARG F 141 CG CD NE CZ NH1 NH2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 CH3 ACE H 1 S1P COA H 101 1.81 REMARK 500 CH3 ACE G 1 S1P COA G 101 1.82 REMARK 500 CH3 ACE L 1 S1P COA L 101 1.82 REMARK 500 CH3 ACE I 1 S1P COA I 101 1.82 REMARK 500 CH3 ACE J 1 S1P COA J 101 1.82 REMARK 500 CH3 ACE K 1 S1P COA K 101 1.83 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 HIS B 65 63.81 -113.79 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for Di-peptide ACE G 1 and MET G 2 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for Di-peptide PRO G 5 and NH2 G 6 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residues COA G 101 and ACE G 1 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for Di-peptide ACE O 1 and MET O 2 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for Di-peptide PRO O 5 and NH2 O 6 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residues COA O 101 and ACE O 1 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for Di-peptide ACE P 1 and MET P 2 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for Di-peptide PRO P 5 and NH2 P 6 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC9 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residues COA P 101 and ACE P 1 REMARK 800 REMARK 800 SITE_IDENTIFIER: AD1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for Di-peptide ACE Q 1 and MET Q 2 REMARK 800 REMARK 800 SITE_IDENTIFIER: AD2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for Di-peptide PRO Q 5 and NH2 Q 6 REMARK 800 REMARK 800 SITE_IDENTIFIER: AD3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residues COA Q 101 and ACE Q 1 REMARK 800 REMARK 800 SITE_IDENTIFIER: AD4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for Di-peptide ACE R 1 and MET R 2 REMARK 800 REMARK 800 SITE_IDENTIFIER: AD5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for Di-peptide PRO R 5 and NH2 R 6 REMARK 800 REMARK 800 SITE_IDENTIFIER: AD6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residues COA R 101 and ACE R 1 REMARK 800 REMARK 800 SITE_IDENTIFIER: AD7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for Di-peptide ACE S 1 and MET S 2 REMARK 800 REMARK 800 SITE_IDENTIFIER: AD8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for Di-peptide PRO S 5 and NH2 S 6 REMARK 800 REMARK 800 SITE_IDENTIFIER: AD9 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residues COA S 101 and ACE S 1 DBREF 6WF3 A 1 169 UNP Q9GZZ1 NAA50_HUMAN 1 169 DBREF 6WF3 B 1 169 UNP Q9GZZ1 NAA50_HUMAN 1 169 DBREF 6WF3 C 1 169 UNP Q9GZZ1 NAA50_HUMAN 1 169 DBREF 6WF3 D 1 169 UNP Q9GZZ1 NAA50_HUMAN 1 169 DBREF 6WF3 E 1 169 UNP Q9GZZ1 NAA50_HUMAN 1 169 DBREF 6WF3 F 1 169 UNP Q9GZZ1 NAA50_HUMAN 1 169 DBREF 6WF3 G 1 6 PDB 6WF3 6WF3 1 6 DBREF 6WF3 H 1 6 PDB 6WF3 6WF3 1 6 DBREF 6WF3 I 1 6 PDB 6WF3 6WF3 1 6 DBREF 6WF3 J 1 6 PDB 6WF3 6WF3 1 6 DBREF 6WF3 K 1 6 PDB 6WF3 6WF3 1 6 DBREF 6WF3 L 1 6 PDB 6WF3 6WF3 1 6 SEQADV 6WF3 GLY A -1 UNP Q9GZZ1 EXPRESSION TAG SEQADV 6WF3 SER A 0 UNP Q9GZZ1 EXPRESSION TAG SEQADV 6WF3 GLY B -1 UNP Q9GZZ1 EXPRESSION TAG SEQADV 6WF3 SER B 0 UNP Q9GZZ1 EXPRESSION TAG SEQADV 6WF3 GLY C -1 UNP Q9GZZ1 EXPRESSION TAG SEQADV 6WF3 SER C 0 UNP Q9GZZ1 EXPRESSION TAG SEQADV 6WF3 GLY D -1 UNP Q9GZZ1 EXPRESSION TAG SEQADV 6WF3 SER D 0 UNP Q9GZZ1 EXPRESSION TAG SEQADV 6WF3 GLY E -1 UNP Q9GZZ1 EXPRESSION TAG SEQADV 6WF3 SER E 0 UNP Q9GZZ1 EXPRESSION TAG SEQADV 6WF3 GLY F -1 UNP Q9GZZ1 EXPRESSION TAG SEQADV 6WF3 SER F 0 UNP Q9GZZ1 EXPRESSION TAG SEQRES 1 A 171 GLY SER MET LYS GLY SER ARG ILE GLU LEU GLY ASP VAL SEQRES 2 A 171 THR PRO HIS ASN ILE LYS GLN LEU LYS ARG LEU ASN GLN SEQRES 3 A 171 VAL ILE PHE PRO VAL SER TYR ASN ASP LYS PHE TYR LYS SEQRES 4 A 171 ASP VAL LEU GLU VAL GLY GLU LEU ALA LYS LEU ALA TYR SEQRES 5 A 171 PHE ASN ASP ILE ALA VAL GLY ALA VAL CYS CYS ARG VAL SEQRES 6 A 171 ASP HIS SER GLN ASN GLN LYS ARG LEU TYR ILE MET THR SEQRES 7 A 171 LEU GLY CYS LEU ALA PRO TYR ARG ARG LEU GLY ILE GLY SEQRES 8 A 171 THR LYS MET LEU ASN HIS VAL LEU ASN ILE CYS GLU LYS SEQRES 9 A 171 ASP GLY THR PHE ASP ASN ILE TYR LEU HIS VAL GLN ILE SEQRES 10 A 171 SER ASN GLU SER ALA ILE ASP PHE TYR ARG LYS PHE GLY SEQRES 11 A 171 PHE GLU ILE ILE GLU THR LYS LYS ASN TYR TYR LYS ARG SEQRES 12 A 171 ILE GLU PRO ALA ASP ALA HIS VAL LEU GLN LYS ASN LEU SEQRES 13 A 171 LYS VAL PRO SER GLY GLN ASN ALA ASP VAL GLN LYS THR SEQRES 14 A 171 ASP ASN SEQRES 1 B 171 GLY SER MET LYS GLY SER ARG ILE GLU LEU GLY ASP VAL SEQRES 2 B 171 THR PRO HIS ASN ILE LYS GLN LEU LYS ARG LEU ASN GLN SEQRES 3 B 171 VAL ILE PHE PRO VAL SER TYR ASN ASP LYS PHE TYR LYS SEQRES 4 B 171 ASP VAL LEU GLU VAL GLY GLU LEU ALA LYS LEU ALA TYR SEQRES 5 B 171 PHE ASN ASP ILE ALA VAL GLY ALA VAL CYS CYS ARG VAL SEQRES 6 B 171 ASP HIS SER GLN ASN GLN LYS ARG LEU TYR ILE MET THR SEQRES 7 B 171 LEU GLY CYS LEU ALA PRO TYR ARG ARG LEU GLY ILE GLY SEQRES 8 B 171 THR LYS MET LEU ASN HIS VAL LEU ASN ILE CYS GLU LYS SEQRES 9 B 171 ASP GLY THR PHE ASP ASN ILE TYR LEU HIS VAL GLN ILE SEQRES 10 B 171 SER ASN GLU SER ALA ILE ASP PHE TYR ARG LYS PHE GLY SEQRES 11 B 171 PHE GLU ILE ILE GLU THR LYS LYS ASN TYR TYR LYS ARG SEQRES 12 B 171 ILE GLU PRO ALA ASP ALA HIS VAL LEU GLN LYS ASN LEU SEQRES 13 B 171 LYS VAL PRO SER GLY GLN ASN ALA ASP VAL GLN LYS THR SEQRES 14 B 171 ASP ASN SEQRES 1 C 171 GLY SER MET LYS GLY SER ARG ILE GLU LEU GLY ASP VAL SEQRES 2 C 171 THR PRO HIS ASN ILE LYS GLN LEU LYS ARG LEU ASN GLN SEQRES 3 C 171 VAL ILE PHE PRO VAL SER TYR ASN ASP LYS PHE TYR LYS SEQRES 4 C 171 ASP VAL LEU GLU VAL GLY GLU LEU ALA LYS LEU ALA TYR SEQRES 5 C 171 PHE ASN ASP ILE ALA VAL GLY ALA VAL CYS CYS ARG VAL SEQRES 6 C 171 ASP HIS SER GLN ASN GLN LYS ARG LEU TYR ILE MET THR SEQRES 7 C 171 LEU GLY CYS LEU ALA PRO TYR ARG ARG LEU GLY ILE GLY SEQRES 8 C 171 THR LYS MET LEU ASN HIS VAL LEU ASN ILE CYS GLU LYS SEQRES 9 C 171 ASP GLY THR PHE ASP ASN ILE TYR LEU HIS VAL GLN ILE SEQRES 10 C 171 SER ASN GLU SER ALA ILE ASP PHE TYR ARG LYS PHE GLY SEQRES 11 C 171 PHE GLU ILE ILE GLU THR LYS LYS ASN TYR TYR LYS ARG SEQRES 12 C 171 ILE GLU PRO ALA ASP ALA HIS VAL LEU GLN LYS ASN LEU SEQRES 13 C 171 LYS VAL PRO SER GLY GLN ASN ALA ASP VAL GLN LYS THR SEQRES 14 C 171 ASP ASN SEQRES 1 D 171 GLY SER MET LYS GLY SER ARG ILE GLU LEU GLY ASP VAL SEQRES 2 D 171 THR PRO HIS ASN ILE LYS GLN LEU LYS ARG LEU ASN GLN SEQRES 3 D 171 VAL ILE PHE PRO VAL SER TYR ASN ASP LYS PHE TYR LYS SEQRES 4 D 171 ASP VAL LEU GLU VAL GLY GLU LEU ALA LYS LEU ALA TYR SEQRES 5 D 171 PHE ASN ASP ILE ALA VAL GLY ALA VAL CYS CYS ARG VAL SEQRES 6 D 171 ASP HIS SER GLN ASN GLN LYS ARG LEU TYR ILE MET THR SEQRES 7 D 171 LEU GLY CYS LEU ALA PRO TYR ARG ARG LEU GLY ILE GLY SEQRES 8 D 171 THR LYS MET LEU ASN HIS VAL LEU ASN ILE CYS GLU LYS SEQRES 9 D 171 ASP GLY THR PHE ASP ASN ILE TYR LEU HIS VAL GLN ILE SEQRES 10 D 171 SER ASN GLU SER ALA ILE ASP PHE TYR ARG LYS PHE GLY SEQRES 11 D 171 PHE GLU ILE ILE GLU THR LYS LYS ASN TYR TYR LYS ARG SEQRES 12 D 171 ILE GLU PRO ALA ASP ALA HIS VAL LEU GLN LYS ASN LEU SEQRES 13 D 171 LYS VAL PRO SER GLY GLN ASN ALA ASP VAL GLN LYS THR SEQRES 14 D 171 ASP ASN SEQRES 1 E 171 GLY SER MET LYS GLY SER ARG ILE GLU LEU GLY ASP VAL SEQRES 2 E 171 THR PRO HIS ASN ILE LYS GLN LEU LYS ARG LEU ASN GLN SEQRES 3 E 171 VAL ILE PHE PRO VAL SER TYR ASN ASP LYS PHE TYR LYS SEQRES 4 E 171 ASP VAL LEU GLU VAL GLY GLU LEU ALA LYS LEU ALA TYR SEQRES 5 E 171 PHE ASN ASP ILE ALA VAL GLY ALA VAL CYS CYS ARG VAL SEQRES 6 E 171 ASP HIS SER GLN ASN GLN LYS ARG LEU TYR ILE MET THR SEQRES 7 E 171 LEU GLY CYS LEU ALA PRO TYR ARG ARG LEU GLY ILE GLY SEQRES 8 E 171 THR LYS MET LEU ASN HIS VAL LEU ASN ILE CYS GLU LYS SEQRES 9 E 171 ASP GLY THR PHE ASP ASN ILE TYR LEU HIS VAL GLN ILE SEQRES 10 E 171 SER ASN GLU SER ALA ILE ASP PHE TYR ARG LYS PHE GLY SEQRES 11 E 171 PHE GLU ILE ILE GLU THR LYS LYS ASN TYR TYR LYS ARG SEQRES 12 E 171 ILE GLU PRO ALA ASP ALA HIS VAL LEU GLN LYS ASN LEU SEQRES 13 E 171 LYS VAL PRO SER GLY GLN ASN ALA ASP VAL GLN LYS THR SEQRES 14 E 171 ASP ASN SEQRES 1 F 171 GLY SER MET LYS GLY SER ARG ILE GLU LEU GLY ASP VAL SEQRES 2 F 171 THR PRO HIS ASN ILE LYS GLN LEU LYS ARG LEU ASN GLN SEQRES 3 F 171 VAL ILE PHE PRO VAL SER TYR ASN ASP LYS PHE TYR LYS SEQRES 4 F 171 ASP VAL LEU GLU VAL GLY GLU LEU ALA LYS LEU ALA TYR SEQRES 5 F 171 PHE ASN ASP ILE ALA VAL GLY ALA VAL CYS CYS ARG VAL SEQRES 6 F 171 ASP HIS SER GLN ASN GLN LYS ARG LEU TYR ILE MET THR SEQRES 7 F 171 LEU GLY CYS LEU ALA PRO TYR ARG ARG LEU GLY ILE GLY SEQRES 8 F 171 THR LYS MET LEU ASN HIS VAL LEU ASN ILE CYS GLU LYS SEQRES 9 F 171 ASP GLY THR PHE ASP ASN ILE TYR LEU HIS VAL GLN ILE SEQRES 10 F 171 SER ASN GLU SER ALA ILE ASP PHE TYR ARG LYS PHE GLY SEQRES 11 F 171 PHE GLU ILE ILE GLU THR LYS LYS ASN TYR TYR LYS ARG SEQRES 12 F 171 ILE GLU PRO ALA ASP ALA HIS VAL LEU GLN LYS ASN LEU SEQRES 13 F 171 LYS VAL PRO SER GLY GLN ASN ALA ASP VAL GLN LYS THR SEQRES 14 F 171 ASP ASN SEQRES 1 G 6 ACE MET LEU GLY PRO NH2 SEQRES 1 H 6 ACE MET LEU GLY PRO NH2 SEQRES 1 I 6 ACE MET LEU GLY PRO NH2 SEQRES 1 J 6 ACE MET LEU GLY PRO NH2 SEQRES 1 K 6 ACE MET LEU GLY PRO NH2 SEQRES 1 L 6 ACE MET LEU GLY PRO NH2 HET ACE G 1 5 HET NH2 G 6 1 HET ACE H 1 5 HET NH2 H 6 1 HET ACE I 1 5 HET NH2 I 6 1 HET ACE J 1 5 HET NH2 J 6 1 HET ACE K 1 5 HET NH2 K 6 1 HET ACE L 1 5 HET NH2 L 6 1 HET COA G 101 79 HET COA H 101 79 HET COA I 101 79 HET COA J 101 79 HET COA K 101 79 HET COA L 101 79 HETNAM ACE ACETYL GROUP HETNAM NH2 AMINO GROUP HETNAM COA COENZYME A FORMUL 7 ACE 6(C2 H4 O) FORMUL 7 NH2 6(H2 N) FORMUL 13 COA 6(C21 H36 N7 O16 P3 S) FORMUL 19 HOH *354(H2 O) HELIX 1 AA1 ASN A 15 PHE A 27 1 13 HELIX 2 AA2 ASN A 32 LEU A 40 1 9 HELIX 3 AA3 GLU A 41 GLU A 44 5 4 HELIX 4 AA4 ALA A 81 ARG A 84 5 4 HELIX 5 AA5 GLY A 87 GLY A 104 1 18 HELIX 6 AA6 ASN A 117 LYS A 126 1 10 HELIX 7 AA7 ASN B 15 PHE B 27 1 13 HELIX 8 AA8 ASN B 32 LEU B 40 1 9 HELIX 9 AA9 GLU B 41 GLU B 44 5 4 HELIX 10 AB1 ALA B 81 ARG B 84 5 4 HELIX 11 AB2 GLY B 87 GLY B 104 1 18 HELIX 12 AB3 ASN B 117 LYS B 126 1 10 HELIX 13 AB4 ASN C 15 PHE C 27 1 13 HELIX 14 AB5 ASN C 32 LEU C 40 1 9 HELIX 15 AB6 GLU C 41 GLU C 44 5 4 HELIX 16 AB7 ALA C 81 ARG C 84 5 4 HELIX 17 AB8 GLY C 87 GLY C 104 1 18 HELIX 18 AB9 ASN C 117 PHE C 127 1 11 HELIX 19 AC1 ASN D 15 PHE D 27 1 13 HELIX 20 AC2 ASN D 32 LEU D 40 1 9 HELIX 21 AC3 GLU D 41 GLU D 44 5 4 HELIX 22 AC4 ALA D 81 ARG D 84 5 4 HELIX 23 AC5 GLY D 87 GLY D 104 1 18 HELIX 24 AC6 ASN D 117 PHE D 127 1 11 HELIX 25 AC7 ASN E 15 PHE E 27 1 13 HELIX 26 AC8 ASN E 32 LEU E 40 1 9 HELIX 27 AC9 GLU E 41 GLU E 44 5 4 HELIX 28 AD1 ALA E 81 ARG E 84 5 4 HELIX 29 AD2 GLY E 87 GLY E 104 1 18 HELIX 30 AD3 ASN E 117 LYS E 126 1 10 HELIX 31 AD4 ASN F 15 PHE F 27 1 13 HELIX 32 AD5 ASN F 32 LEU F 40 1 9 HELIX 33 AD6 GLU F 41 GLU F 44 5 4 HELIX 34 AD7 ALA F 81 ARG F 84 5 4 HELIX 35 AD8 GLY F 87 GLY F 104 1 18 HELIX 36 AD9 ASN F 117 PHE F 127 1 11 SHEET 1 AA1 7 ILE A 6 ASP A 10 0 SHEET 2 AA1 7 ALA A 46 PHE A 51 -1 O TYR A 50 N GLU A 7 SHEET 3 AA1 7 ILE A 54 SER A 66 -1 O ILE A 54 N PHE A 51 SHEET 4 AA1 7 GLN A 69 CYS A 79 -1 O TYR A 73 N ARG A 62 SHEET 5 AA1 7 ASN A 108 GLN A 114 1 O TYR A 110 N ILE A 74 SHEET 6 AA1 7 ALA A 147 ASN A 153 -1 O LYS A 152 N ILE A 109 SHEET 7 AA1 7 GLU A 130 LYS A 135 -1 N LYS A 135 O ALA A 147 SHEET 1 AA2 7 ILE B 6 ASP B 10 0 SHEET 2 AA2 7 ALA B 46 PHE B 51 -1 O TYR B 50 N GLU B 7 SHEET 3 AA2 7 ILE B 54 ASP B 64 -1 O GLY B 57 N ALA B 49 SHEET 4 AA2 7 ARG B 71 CYS B 79 -1 O ARG B 71 N ASP B 64 SHEET 5 AA2 7 ASN B 108 GLN B 114 1 O TYR B 110 N LEU B 72 SHEET 6 AA2 7 ALA B 147 ASN B 153 -1 O HIS B 148 N VAL B 113 SHEET 7 AA2 7 GLU B 130 LYS B 135 -1 N LYS B 135 O ALA B 147 SHEET 1 AA3 7 ILE C 6 ASP C 10 0 SHEET 2 AA3 7 ALA C 46 PHE C 51 -1 O TYR C 50 N GLU C 7 SHEET 3 AA3 7 ILE C 54 SER C 66 -1 O GLY C 57 N ALA C 49 SHEET 4 AA3 7 GLN C 69 CYS C 79 -1 O ARG C 71 N ASP C 64 SHEET 5 AA3 7 ASN C 108 GLN C 114 1 O ASN C 108 N LEU C 72 SHEET 6 AA3 7 ALA C 147 ASN C 153 -1 O LYS C 152 N ILE C 109 SHEET 7 AA3 7 GLU C 130 LYS C 135 -1 N LYS C 135 O ALA C 147 SHEET 1 AA4 7 ILE D 6 ASP D 10 0 SHEET 2 AA4 7 ALA D 46 PHE D 51 -1 O LEU D 48 N GLY D 9 SHEET 3 AA4 7 ILE D 54 ASP D 64 -1 O ILE D 54 N PHE D 51 SHEET 4 AA4 7 ARG D 71 CYS D 79 -1 O ARG D 71 N ASP D 64 SHEET 5 AA4 7 ASN D 108 GLN D 114 1 O TYR D 110 N LEU D 72 SHEET 6 AA4 7 ALA D 147 ASN D 153 -1 O LYS D 152 N ILE D 109 SHEET 7 AA4 7 GLU D 130 LYS D 135 -1 N GLU D 133 O VAL D 149 SHEET 1 AA5 7 ILE E 6 ASP E 10 0 SHEET 2 AA5 7 ALA E 46 PHE E 51 -1 O LEU E 48 N GLY E 9 SHEET 3 AA5 7 ILE E 54 SER E 66 -1 O GLY E 57 N ALA E 49 SHEET 4 AA5 7 GLN E 69 CYS E 79 -1 O THR E 76 N CYS E 60 SHEET 5 AA5 7 ASN E 108 GLN E 114 1 O TYR E 110 N LEU E 72 SHEET 6 AA5 7 ALA E 147 ASN E 153 -1 O LYS E 152 N ILE E 109 SHEET 7 AA5 7 GLU E 130 LYS E 135 -1 N GLU E 133 O VAL E 149 SHEET 1 AA6 7 ILE F 6 ASP F 10 0 SHEET 2 AA6 7 ALA F 46 PHE F 51 -1 O TYR F 50 N GLU F 7 SHEET 3 AA6 7 ILE F 54 SER F 66 -1 O GLY F 57 N ALA F 49 SHEET 4 AA6 7 GLN F 69 CYS F 79 -1 O ARG F 71 N ASP F 64 SHEET 5 AA6 7 ASN F 108 GLN F 114 1 O TYR F 110 N LEU F 72 SHEET 6 AA6 7 ALA F 147 ASN F 153 -1 O LYS F 152 N ILE F 109 SHEET 7 AA6 7 GLU F 130 LYS F 135 -1 N ILE F 132 O VAL F 149 LINK C ACE G 1 N MET G 2 1555 1555 1.34 LINK C PRO G 5 N NH2 G 6 1555 1555 1.35 LINK C ACE H 1 N MET H 2 1555 1555 1.33 LINK C PRO H 5 N NH2 H 6 1555 1555 1.35 LINK C ACE I 1 N MET I 2 1555 1555 1.34 LINK C PRO I 5 N NH2 I 6 1555 1555 1.34 LINK C ACE J 1 N MET J 2 1555 1555 1.34 LINK C PRO J 5 N NH2 J 6 1555 1555 1.34 LINK C ACE K 1 N MET K 2 1555 1555 1.35 LINK C PRO K 5 N NH2 K 6 1555 1555 1.34 LINK C ACE L 1 N MET L 2 1555 1555 1.34 LINK C PRO L 5 N NH2 L 6 1555 1555 1.34 CISPEP 1 GLU A 143 PRO A 144 0 -0.74 CISPEP 2 GLU B 143 PRO B 144 0 -1.27 CISPEP 3 GLU C 143 PRO C 144 0 -1.65 CISPEP 4 GLU D 143 PRO D 144 0 -2.84 CISPEP 5 GLU E 143 PRO E 144 0 1.66 CISPEP 6 GLU F 143 PRO F 144 0 0.93 SITE 1 AC1 14 PHE A 27 PRO A 28 VAL A 29 TYR A 31 SITE 2 AC1 14 ILE A 74 MET A 75 THR A 76 LEU A 77 SITE 3 AC1 14 HIS A 112 TYR A 139 HOH A 210 LEU G 3 SITE 4 AC1 14 GLY G 4 COA G 101 SITE 1 AC2 3 SER A 30 LEU G 3 GLY G 4 SITE 1 AC3 27 ILE A 26 PHE A 27 ILE A 74 MET A 75 SITE 2 AC3 27 THR A 76 LEU A 77 GLY A 78 CYS A 79 SITE 3 AC3 27 ARG A 84 ARG A 85 LEU A 86 GLY A 87 SITE 4 AC3 27 ILE A 88 GLY A 89 THR A 90 VAL A 113 SITE 5 AC3 27 ASN A 117 SER A 119 ASP A 122 PHE A 123 SITE 6 AC3 27 TYR A 124 LYS A 126 HOH A 201 MET G 2 SITE 7 AC3 27 HOH G 201 HOH G 202 HOH G 203 SITE 1 AC4 14 PHE B 27 PRO B 28 VAL B 29 TYR B 31 SITE 2 AC4 14 MET B 75 THR B 76 LEU B 77 HIS B 112 SITE 3 AC4 14 GLN B 114 TYR B 139 HOH B 205 LEU H 3 SITE 4 AC4 14 GLY H 4 COA H 101 SITE 1 AC5 3 SER B 30 LEU H 3 GLY H 4 SITE 1 AC6 28 ILE B 26 PHE B 27 MET B 75 THR B 76 SITE 2 AC6 28 LEU B 77 GLY B 78 CYS B 79 ARG B 84 SITE 3 AC6 28 ARG B 85 LEU B 86 GLY B 87 ILE B 88 SITE 4 AC6 28 GLY B 89 THR B 90 VAL B 113 ASN B 117 SITE 5 AC6 28 SER B 119 ALA B 120 ASP B 122 PHE B 123 SITE 6 AC6 28 TYR B 124 LYS B 126 HOH B 201 MET H 2 SITE 7 AC6 28 HOH H 201 HOH H 202 HOH H 203 HOH H 204 SITE 1 AC7 13 PHE C 27 PRO C 28 TYR C 31 ILE C 74 SITE 2 AC7 13 MET C 75 THR C 76 LEU C 77 HIS C 112 SITE 3 AC7 13 TYR C 139 HOH C 216 LEU I 3 GLY I 4 SITE 4 AC7 13 COA I 101 SITE 1 AC8 3 SER C 30 LEU I 3 GLY I 4 SITE 1 AC9 29 ILE C 26 PHE C 27 ILE C 74 MET C 75 SITE 2 AC9 29 THR C 76 LEU C 77 GLY C 78 CYS C 79 SITE 3 AC9 29 ARG C 84 ARG C 85 LEU C 86 GLY C 87 SITE 4 AC9 29 GLY C 89 THR C 90 ASN C 117 SER C 119 SITE 5 AC9 29 ALA C 120 ASP C 122 PHE C 123 TYR C 124 SITE 6 AC9 29 LYS C 126 HOH C 202 MET I 2 HOH I 201 SITE 7 AC9 29 HOH I 202 HOH I 203 HOH I 204 HOH I 205 SITE 8 AC9 29 HOH I 206 SITE 1 AD1 14 PHE D 27 PRO D 28 VAL D 29 TYR D 31 SITE 2 AD1 14 MET D 75 THR D 76 LEU D 77 HIS D 112 SITE 3 AD1 14 GLN D 114 TYR D 139 HOH D 218 LEU J 3 SITE 4 AD1 14 GLY J 4 COA J 101 SITE 1 AD2 5 HOH D 250 LEU J 3 GLY J 4 HOH J 205 SITE 2 AD2 5 HOH J 206 SITE 1 AD3 28 ILE D 26 PHE D 27 MET D 75 THR D 76 SITE 2 AD3 28 LEU D 77 GLY D 78 CYS D 79 ARG D 84 SITE 3 AD3 28 ARG D 85 LEU D 86 GLY D 87 ILE D 88 SITE 4 AD3 28 GLY D 89 THR D 90 HIS D 112 ASN D 117 SITE 5 AD3 28 SER D 119 ASP D 122 PHE D 123 TYR D 124 SITE 6 AD3 28 LYS D 126 HOH D 203 MET J 2 HOH J 201 SITE 7 AD3 28 HOH J 202 HOH J 203 HOH J 204 HOH J 207 SITE 1 AD4 12 PHE E 27 PRO E 28 TYR E 31 ILE E 74 SITE 2 AD4 12 MET E 75 THR E 76 LEU E 77 HIS E 112 SITE 3 AD4 12 TYR E 139 LEU K 3 GLY K 4 COA K 101 SITE 1 AD5 3 SER E 30 LEU K 3 GLY K 4 SITE 1 AD6 28 ILE E 26 PHE E 27 ILE E 74 MET E 75 SITE 2 AD6 28 THR E 76 LEU E 77 GLY E 78 CYS E 79 SITE 3 AD6 28 ARG E 84 ARG E 85 LEU E 86 GLY E 87 SITE 4 AD6 28 ILE E 88 GLY E 89 THR E 90 HIS E 112 SITE 5 AD6 28 VAL E 113 ASN E 117 SER E 119 ALA E 120 SITE 6 AD6 28 ASP E 122 PHE E 123 TYR E 124 LYS E 126 SITE 7 AD6 28 MET K 2 HOH K 201 HOH K 202 HOH K 203 SITE 1 AD7 11 PHE F 27 PRO F 28 TYR F 31 MET F 75 SITE 2 AD7 11 THR F 76 LEU F 77 HIS F 112 TYR F 139 SITE 3 AD7 11 HOH F 204 LEU L 3 COA L 101 SITE 1 AD8 3 SER F 30 LEU L 3 GLY L 4 SITE 1 AD9 26 ILE F 26 PHE F 27 MET F 75 THR F 76 SITE 2 AD9 26 LEU F 77 GLY F 78 CYS F 79 ARG F 84 SITE 3 AD9 26 ARG F 85 LEU F 86 GLY F 87 ILE F 88 SITE 4 AD9 26 GLY F 89 THR F 90 ASN F 117 SER F 119 SITE 5 AD9 26 ALA F 120 ASP F 122 PHE F 123 TYR F 124 SITE 6 AD9 26 LYS F 126 HOH F 201 MET L 2 HOH L 201 SITE 7 AD9 26 HOH L 202 HOH L 203 CRYST1 48.547 124.170 109.085 90.00 100.92 90.00 P 1 21 1 12 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.020599 0.000000 0.003974 0.00000 SCALE2 0.000000 0.008053 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009336 0.00000